Virax Biolabs Group Ltd. Class A's total assets for Q2 2025 were $9.44M, an increase of 72.19% from the previous quarter. VRAX total liabilities were $1.03M for the fiscal quarter, a 197.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.